A CXCR1 and CXCR2 antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SCH 563705

Item No. 43479

Technical Information
Formal Name
2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-[4-(1-methylethyl)-2-furanyl]propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]-benzamide
CAS Number
473728-58-4
Molecular Formula
C23H27N3O5
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
O=C(C1=O)C(N[C@@H](C2=CC(C(C)C)=CO2)CC)=C1NC3=C(O)C(C(N(C)C)=O)=CC=C3
InChi Code
InChI=1S/C23H27N3O5/c1-6-15(17-10-13(11-31-17)12(2)3)24-18-19(22(29)21(18)28)25-16-9-7-8-14(20(16)27)23(30)26(4)5/h7-12,15,24-25,27H,6H2,1-5H3/t15-/m1/s1
InChi Key
DGKQQEVYYPCMNE-OAHLLOKOSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    SCH 563705 is an antagonist of chemokine (C-X-C motif) receptor 1 (CXCR1) and CXCR2 (Kis = 7.3 and 1.3 nM, respectively).1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Winkel, A.F., Engel, C.K., Margerie, D., et alCharacterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling. The Journal of Biological Chemisty 290(47), 27446-28455 (2015).